These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16004556)

  • 1. The application of RAGE and GECKO in cell-based target discovery screens.
    Brunden K; Sherf B; Harrington J
    Pharmacogenomics; 2005 Jun; 6(4):383-92. PubMed ID: 16004556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical genetics-based target identification in drug discovery.
    Cong F; Cheung AK; Huang SM
    Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caenorhabditis elegans: a versatile platform for drug discovery.
    Artal-Sanz M; de Jong L; Tavernarakis N
    Biotechnol J; 2006 Dec; 1(12):1405-18. PubMed ID: 17109493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of whole-genome association scans in disease gene identification, drug discovery and development.
    Roses AD; St Jean PL; Ehm MG
    IDrugs; 2007 Nov; 10(11):797-804. PubMed ID: 17968762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens.
    Perrimon N; Friedman A; Mathey-Prevot B; Eggert US
    Drug Discov Today; 2007 Jan; 12(1-2):28-33. PubMed ID: 17198970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA amplification techniques in pharmacogenomics.
    Morlighem JÉ; Harbers M; Traeger-Synodinos J; Lezhava A
    Pharmacogenomics; 2011 Jun; 12(6):845-60. PubMed ID: 21692615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic approaches to drug discovery.
    Ricke DO; Wang S; Cai R; Cohen D
    Curr Opin Chem Biol; 2006 Aug; 10(4):303-8. PubMed ID: 16822705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic target discovery using Caenorhabditis elegans.
    Link EM; Hardiman G; Sluder AE; Johnson CD; Liu LX
    Pharmacogenomics; 2000 May; 1(2):203-17. PubMed ID: 11256592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical genetics: Drug screens in Zebrafish.
    den Hertog J
    Biosci Rep; 2005; 25(5-6):289-97. PubMed ID: 16307377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense and RNAi: powerful tools in drug target discovery and validation.
    Lavery KS; King TH
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):561-9. PubMed ID: 12951819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets.
    Hardy LW; Peet NP
    Drug Discov Today; 2004 Feb; 9(3):117-26. PubMed ID: 14960389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methods of experimental validation of potential target proteins for creation of new drugs].
    Ivanov AS; Veselovskiĭ AV; Archakov AI
    Biomed Khim; 2005; 51(1):2-18. PubMed ID: 15850214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.
    Kramer JA; Sagartz JE; Morris DL
    Nat Rev Drug Discov; 2007 Aug; 6(8):636-49. PubMed ID: 17643090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards high-throughput characterization of small molecule mechanisms of action.
    Luesch H
    Mol Biosyst; 2006 Dec; 2(12):609-20. PubMed ID: 17216042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery and delivery in the 21st century.
    Triggle DJ
    Med Princ Pract; 2007; 16(1):1-14. PubMed ID: 17159357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
    Outeiro TF; Giorgini F
    Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets.
    Vogt A; Lazo JS
    Pharmacol Ther; 2005 Aug; 107(2):212-21. PubMed ID: 15925410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How will RNAi facilitate drug development?
    Bartz S; Jackson AL
    Sci STKE; 2005 Aug; 2005(295):pe39. PubMed ID: 16077085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of both gene expression and protein stability provides genetically assisted target evaluation (GATE) for microbial target validation.
    Buurman ET; Bradley JD; Donnelly CE; Moore JB; Healy JM; Averett DR; Thompson CM; Wobbe CR
    Pharmacogenomics; 2001 May; 2(2):95-106. PubMed ID: 11368749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.